Biotechnology VALUE FUND II L.P., Director, 10% Owner at Olema Pharmaceuticals, Inc. (OLMA), bought 1,208,733 shares at $19.00 ($21.6M) on 2020-11-19, disclosed to the SEC on 2020-11-20.
High-signal trade — passes our conviction filters but the AI narrative is still being generated. Check back shortly.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $0.00 | 73,399 | $0 | 0.0% |
| 2 | $19.00 | 74,991 | $1.4M | 6.6% |
| 3 | $19.00 | 446,425 | $8.5M | 39.3% |
| 4 | $19.00 | 613,918 | $11.7M | 54.1% |
| Total | $17.85 avg | 1,208,733 | $21.6M | 100% |
| Filing → |
| THRD | BUY | 2022-12-22 | $1.7M | — | Filing → |
| KYMR | BUY | 2022-08-23 | $14.2M | — | Filing → |
| RPTX | BUY | 2022-06-15 | $3.8M | — | Filing → |